BioSig Technologies, Inc.·4/A

Dec 5, 6:15 PM ET

Fleming Gray 4/A

4/A · BioSig Technologies, Inc. · Filed Dec 5, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-11-30
Fleming Gray
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2023-11-30+131,900463,556 total
Footnotes (2)
  • [F1]On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock.
  • [F2]The shares of restricted stock fully vested on November 30, 2023, the date of the grant.

Documents

1 file
  • 4
    ownership.xml